Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
批准号:
10527264
负责人:
Wiljeana Glover
金额:
$29.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-15 至 2027-06-30
关键词:
Active LearningAddressBasic ScienceBiological SciencesBusinessesCommunitiesCoupledCustomDecision MakingDevelopmentDevicesDiagnostic EquipmentDrug AddictionEconomic DevelopmentEducationEducational CurriculumElectronic MailEmerging TechnologiesEntrepreneurshipEnvironmentFacultyFutureGoalsGrowthHealthHealthcareImmersionIndividualIndustryIntellectual PropertyMarketingMechanicsMobile Health ApplicationNational Institute of Drug AbuseNeurosciencesNewsletterOrganizational CultureOutcomeParticipantPatient RecruitmentsPersonal SatisfactionPharmaceutical PreparationsPublic HealthResearchResearch PersonnelRewardsRoleScientistStructureSubstance Use DisorderTechniquesTechnologyTherapeuticThinkingTrainingUncertaintyUnited StatesUnited States National Institutes of HealthWorkbasecollegecommercializationcommunity buildingcurriculum developmentexperienceimprovedinnovationinterestnew technologyorganizational structureoutreachproduct developmentprogramsrecruitskill acquisitionsubstance use treatmentsymposiumtool
中文摘要
项目摘要
巴布森生命科学创业产品开发沉浸式新
技术和解决方案(巴布森L-SPRINT)计划
商业化的创新和新的企业,以解决某些条件,包括
解决物质使用障碍的原因、后果和治疗的企业
(SUD),以改善个人和公共健康,仍然代表性不足,其中最近
创业公司商业化和基于技术的初创企业在学术界可能具有挑战性,
由于不同的奖励结构,组织结构和组织环境
cultures.许多有前途的科学家不愿寻求知识产权保护
并调查商业化的机会,即使是独特的研究成果,由于缺乏
对产品化和商业化机制的理解。
为了解决这些误解和挑战,同时扩大
学术科学家可以解决SUD,巴布森生命科学创业
新技术和解决方案的产品开发沉浸式课程(巴布森L-SPRINT)
该计划将接触到对产品开发和商业化感兴趣的科学家,
培训参与者的创业思维,也可以增加决策,提高
他们的组织和实验室从内部,特别是因为产品开发在生物医学
工业是非常不确定的。巴布森L-SPRINT计划包括两个目标:
目标1:课程开发-巴布森L-SPRINT计划将开发一个专业的
课程强调巴布森的签名创业思想和行动®提供耦合
提供定制的医疗保健和生物医学创业内容,
细分和不确定性,新兴技术的商业化,扩展增长,以及
生物医学界的经验。该计划将使用现场情况下,面板,和其他
体验式学习技术。
目标2:技能发展课程-我们还将制定一项招聘和外联方案,
战略采用创新的全渠道方法,包括利用电子邮件进行直接营销,
相关会议,并通过NIH NIDA通讯和其他可用媒体。
英文摘要
PROJECT SUMMARY
Babson Life Sciences Entrepreneurial Product Development Immersion for New
Technologies and Solutions (Babson L-SPRINT) Program
Commercialized innovations and new ventures that address certain conditions, including
ventures that address the causes, consequences, and treatment of substance use disorders
(SUDs) to improve individual and public health, are still underrepresented amongst recent
startups. Commercialization and technology-based start-ups can be challenging in an academic
environment due to varying reward structures, organizational structures and organizational
cultures. Many promising scientists are reluctant to pursue intellectual property (IP) protection
and investigate commercialization opportunities, even for unique research findings, due to a lack
of understanding of the mechanics towards productizing and commercialization.
To address these misperceptions and challenges while amplifying the potential impact that
academic scientists can make to address SUDs, the Babson Life Sciences Entrepreneurial
Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT)
Program will reach scientists interested in product development and commercialization as well as
to train participants in entrepreneurial thinking that can also increase decision making, improve
their organizations and labs from within, especially since product development in the biomedical
industry is highly uncertain. The Babson L-SPRINT Program includes two aims:
Aim 1: Curriculum Development--The Babson L-SPRINT program will develop a specialized
curriculum highlighting Babson’s signature Entrepreneurial Thought & Action ® offering coupled
with customized healthcare and biomedical entrepreneurship content on addressing market
segmentation and uncertainty, commercializing emerging technologies, scaling for growth, and
biomedical community experiences. The program will use live cases, panels, and other
experiential learning techniques.
Aim 2: Courses for Skills Development--We will also develop a recruitment and outreach
strategy using an innovative omnichannel approach including direct marketing utilizing email,
relevant conferences, and via NIH NIDA newsletters and other media as available.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program
-
批准号:10678869
-
项目类别:
-
资助金额:$31.62万
-
财政年份:2022
-
负责人:Wiljeana Glover
-
依托单位:
海外基金